Regeneron Pharmaceuticals (REGN) Gross Margin (2009 - 2026)
Regeneron Pharmaceuticals (REGN) recorded Gross Margin of 86.56% in Q2 2026, up 0.99 percentage points from 85.58% a year earlier and up 5.13 percentage points from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Gross Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Regeneron Pharmaceuticals' Gross Margin came in at 84.86% as of Jun 30, 2026, down 0.71 percentage points year-over-year; for FY2025, it came in at 85.35%, down 0.77 percentage points from FY2024.
- Annual Gross Margin has declined for three straight years, with a five-year change of -1.47 percentage points (FY2020 to FY2025).
- Across earlier years, Gross Margin came in at 86.13% in FY2024 (-0.03 pp), 86.16% in FY2023 (-1.02 pp), 87.18% in FY2022 (+2.35 pp) and 84.83% in FY2021 (-1.99 pp).
- The Q2 2026 figure is the highest quarterly Gross Margin since Q3 2024.
- On a year-over-year basis, Gross Margin rose in two of the last eight quarters, with an average year-over-year change of -0.70 percentage points.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 4.01 percentage points in Q4 2022, against a drop of 5.27 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at 81.43% (Q1 2026), 84.95% (Q4 2025) and 86.11% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 72.78% |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 86.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.56% |
| Mar 31, 2026 | 81.43% |
| Dec 31, 2025 | 84.95% |
| Sep 30, 2025 | 86.11% |
| Jun 30, 2025 | 85.58% |
| Mar 31, 2025 | 84.67% |
| Dec 31, 2024 | 85.08% |
| Sep 30, 2024 | 86.80% |
| Jun 30, 2024 | 86.46% |
| Mar 31, 2024 | 86.21% |
| Dec 31, 2023 | 84.95% |
| Sep 30, 2023 | 87.02% |
| Jun 30, 2023 | 87.18% |
| Mar 31, 2023 | 85.53% |
| Dec 31, 2022 | 84.17% |
| Sep 30, 2022 | 89.18% |
| Jun 30, 2022 | 89.60% |
| Mar 31, 2022 | 86.34% |
| Dec 31, 2021 | 80.16% |
| Sep 30, 2021 | 86.87% |
API Access
Regeneron Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();